Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2021 May 10;23(11):2233. doi: 10.1038/s41436-021-01188-9

Correction to: 1-13C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA)

Irini Manoli 1, Alexandra R Pass 1, Elizabeth A Harrington 1, Jennifer L Sloan 1, Jack Gagné 1, Samantha McCoy 1, Sarah L Bell 2, Jacob D Hattenbach 2, Brooks P Leitner 2, Courtney J Duckworth 2, Laura A Fletcher 2, Thomas M Cassimatis 2, Carolina I Galarreta 1, Audrey Thurm 3, Joseph Snow 4, Carol Van Ryzin 1, Susan Ferry 1, Nicholas Ah Mew 5, Oleg A Shchelochkov 1, Kong Y Chen 2, Charles P Venditti 1,
PMCID: PMC8553604  PMID: 33972722

Correction to: Genetics in Medicine 2021; 10.1038/s41436-021-01143-8; published online 05 April 2021

Due to a processing error, the online graphical abstract was not given.graphic file with name 41436_2021_1188_Figa_HTML.jpg

The original article has been corrected.


Articles from Genetics in Medicine are provided here courtesy of Nature Publishing Group

RESOURCES